Silk Road Medical saw the highest growth of 0.99% in patent filings and 1.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 1.49%. GlobalData’s DataBook provides a comprehensive analysis of Silk Road Medical’s patent filings and grants. Buy the databook here.
Silk Road Medical has been focused on protecting inventions in European Patent Office(EPO) with three publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 33% filings and 50% grants. The European Patent Office(EPO), United States(US), World Intellectual Property Organization(WIPO), and Australia(AU) patent Office are among the top ten patent offices where Silk Road Medical is filings its patents. Among the top granted patent authorities, Silk Road Medical has 50% of its grants in European Patent Office(EPO), 25% in Australia(AU) and 25% in Spain(ES).
DiNAQOR and Tufts University could be the strongest competitors for Silk Road Medical
Patents related to healthtech lead Silk Road Medical's portfolio
Silk Road Medical has the highest number of patents in healthtech. For healthtech no patents were filed and 100% of patents were granted in Q2 2024.
General surgery devices related patents lead Silk Road Medical portfolio
Silk Road Medical has highest number of patents in general surgery devices. For general surgery devices, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Silk Road Medical's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.